@inproceedings{inproceedings, title = {{Dupilumab treatment is associated with reductions in serum immunoglobulin E and thymus and activation-regulated chemokine levels in children aged 6 to 11 years with severe atopic dermatitis}}, url = {{}}, year = {{2022}}, month = {{1}}, author = {{Cork MJ and Wollenberg A and Siegfried E and Chen Z and Levit NA and Rodriguez Marco A}}, volume = {{52}}, journal = {{CLINICAL AND EXPERIMENTAL ALLERGY}}, issue = {{8}}, pages = {{1059-1059}}, note = {{Accessed on 2025/07/20}}}